These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12015268)

  • 1. Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography-mass spectrometry.
    Staack RF; Fritschi G; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jun; 773(1):35-46. PubMed ID: 12015268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New designer drug 1-(3,4-methylenedioxybenzyl) piperazine (MDBP): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.
    Staack RF; Maurer HH
    J Mass Spectrom; 2004 Mar; 39(3):255-61. PubMed ID: 15039932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urine.
    Staack RF; Fritschi G; Maurer HH
    J Mass Spectrom; 2003 Sep; 38(9):971-81. PubMed ID: 14505325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperazine-derived designer drug 1-(3-chlorophenyl)piperazine (mCPP): GC-MS studies on its metabolism and its toxicological detection in rat urine including analytical differentiation from its precursor drugs trazodone and nefazodone.
    Staack RF; Maurer HH
    J Anal Toxicol; 2003; 27(8):560-8. PubMed ID: 14670134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry.
    Staack RF; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Dec; 798(2):333-42. PubMed ID: 14643514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine.
    Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nishikawa M; Nakajima K; Tsuchihashi H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):315-22. PubMed ID: 15833296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and toxicological detection of a new designer drug, N-(1-phenylcyclohexyl)propanamine, in rat urine using gas chromatography-mass spectrometry.
    Sauer C; Peters FT; Staack RF; Fritschi G; Maurer HH
    J Chromatogr A; 2008 Apr; 1186(1-2):380-90. PubMed ID: 18035363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designer drug 2,4,5-trimethoxyamphetamine (TMA-2): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
    Ewald AH; Fritschi G; Maurer HH
    J Mass Spectrom; 2006 Sep; 41(9):1140-8. PubMed ID: 16810708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low resolution and high resolution MS for studies on the metabolism and toxicological detection of the new psychoactive substance methoxypiperamide (MeOP).
    Meyer MR; Holderbaum A; Kavanagh P; Maurer HH
    J Mass Spectrom; 2015 Oct; 50(10):1163-74. PubMed ID: 26456786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New designer drug 2,5-dimethoxy-4-ethylthio-beta-phenethylamine (2C-T-2): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.
    Theobald DS; Staack RF; Puetz M; Maurer HH
    J Mass Spectrom; 2005 Sep; 40(9):1157-72. PubMed ID: 16041763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and the urinary excretion profile of the recently scheduled designer drug N-Benzylpiperazine (BZP) in the rat.
    Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nakajima K; Inoue H; Kishi T; Tsuchihashi H
    J Anal Toxicol; 2006; 30(1):38-43. PubMed ID: 16620530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and toxicological detection of the designer drug N-(1-phenylcyclohexyl)-3-methoxypropanamine (PCMPA) in rat urine using gas chromatography-mass spectrometry.
    Sauer C; Peters FT; Staack RF; Fritschi G; Maurer HH
    Forensic Sci Int; 2008 Oct; 181(1-3):47-51. PubMed ID: 18922655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New designer drugs N-(1-phenylcyclohexyl)-2-ethoxyethanamine (PCEEA) and N-(1-phenylcyclohexyl)-2-methoxyethanamine (PCMEA): Studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
    Sauer C; Peters FT; Staack RF; Fritschi G; Maurer HH
    J Mass Spectrom; 2008 Mar; 43(3):305-16. PubMed ID: 17968862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New designer drug N-(1-phenylcyclohexyl)-3-ethoxypropanamine (PCEPA): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
    Sauer C; Peters FT; Staack RF; Fritschi G; Maurer HH
    J Mass Spectrom; 2006 Aug; 41(8):1014-29. PubMed ID: 16817170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designer drugs 2,5-dimethoxy-4-bromo-amphetamine (DOB) and 2,5-dimethoxy-4-bromo-methamphetamine (MDOB): studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
    Ewald AH; Fritschi G; Bork WR; Maurer HH
    J Mass Spectrom; 2006 Apr; 41(4):487-98. PubMed ID: 16470568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the toxicological detection of the designer drug 4-bromo-2,5-dimethoxy-beta-phenethylamine (2C-B) in rat urine using gas chromatography-mass spectrometry.
    Theobald DS; Fritschi G; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):374-7. PubMed ID: 16978931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the metabolism and the toxicological analysis of the nootropic drug fipexide in rat urine using gas chromatography-mass spectrometry.
    Staack RF; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 May; 804(2):337-43. PubMed ID: 15081928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New designer drug 4-iodo-2,5-dimethoxy-beta-phenethylamine (2C-I): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric and capillary electrophoretic/mass spectrometric techniques.
    Theobald DS; Pütz M; Schneider E; Maurer HH
    J Mass Spectrom; 2006 Jul; 41(7):872-86. PubMed ID: 16810648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxy-amphetamine (DOI) in rat urine using gas chromatography-mass spectrometry.
    Ewald AH; Fritschi G; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):170-4. PubMed ID: 17632045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography-mass spectrometry.
    Ewald AH; Peters FT; Weise M; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):123-31. PubMed ID: 16027051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.